BiotechTubeBiotechTube
Home/Bicara Therapeutics/David Donabedian
DD

David Donabedian

Chief Technology Officer

Bicara Therapeutics

Therapeutic Areas

OncologySolid Tumors

Bicara Therapeutics Pipeline

DrugIndicationPhase
BCA101Head and Neck Squamous Cell Carcinoma (HNSCC)Phase 1/2

Leadership Team at Bicara Therapeutics

CM
Claire Mazumdar
Chief Executive Officer
MV
Mark Velleca
Chief Scientific Officer
MK
Michele Korfin
Chief Operating and Financial Officer
LP
Lini Pandite
Chief Medical Officer
KB
Kevin Bitterman
Chairman of the Board
CR
Carlo Rizzuto
Board Member
RG
Robert Gottlieb
Board Member
RS
Rajeev Shah
Board Member
BP
Boris Peaker
Board Member
RS
Robert Schreiber
Scientific Advisory Board Member
View full Bicara Therapeutics profile